{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:44:53Z","timestamp":1793213093835,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bendamustine, used for the treatment of indolent B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia, is known to cause prolonged myelosuppression and lymphocytopenia and has been associated with the risk of developing serious and fatal infections. While reports of localized CMV infections in asymptomatic patients exist, disseminated CMV disease has not been described.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the first case of disseminated CMV infection in a 75-year-old male diagnosed with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia with massive bone marrow infiltration. Despite 6-cycle R-bendamustine chemotherapy resulted in a good partial response, the patient developed persistent fever and severe weight loss. Analysis of cerebrospinal fluid and peripheral blood revealed the presence of CMV-DNA, while the fundus oculi examination revealed bilateral CMV retinitis. Treatment with induction and maintenance drugs was complicated by neutropenia and deterioration of renal function with electrolyte imbalance. From an immunological standpoint, we observed a profound imbalances in phenotype and function of B- and T-cell subsets, with a high proportion of circulating total, activated CD69+ and CD80+ B-cells, a low \u03b3\/\u03b4 T-cell frequency with a high proportion of CD69- and CD38-expressing cells, and hyperactivated\/exhausted CD4+ and CD8+ T-cell phenotypes unable to face CMV challenge.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We hereby describe a severe form of disseminated CMV disease after R-bendamustine treatment. Our observations strongly support the careful clinical monitoring of CMV reactivation\/infection in oncologic patients undergoing this therapeutic regimen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4545-7","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:26:01Z","timestamp":1571826361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets"],"prefix":"10.1186","volume":"19","author":[{"given":"Andrea","family":"Cona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tesoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Chiamenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daris","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Codec\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Tincati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"d\u2019Arminio Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-4828","authenticated-orcid":false,"given":"Giulia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"4545_CR1","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1038\/bcj.2015.86","volume":"5","author":"H Saito","year":"2015","unstructured":"Saito H, Maruyama D, Maeshima AM, Makita S, Kitahara H, Miyamoto K, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, et al. Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma. Blood Cancer J. 2015;5:e362.","journal-title":"Blood Cancer J"},{"issue":"9","key":"4545_CR2","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3109\/10428194.2015.1126589","volume":"57","author":"N Isono","year":"2016","unstructured":"Isono N, Imai Y, Watanabe A, Moriya K, Tamura H, Inokuchi K, Asano C, Masuda M, Shimura H, Mitsuhashi K, et al. Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine. Leuk Lymphoma. 2016;57(9):2204\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4545_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hon.2350","volume":"35","author":"A Gafter-Gvili","year":"2017","unstructured":"Gafter-Gvili A, Gurion R, Raanani P, Shpilberg O, Vidal L. Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials. Hematol Oncol. 2017;35(4):424\u201331.","journal-title":"Hematol Oncol"},{"issue":"4","key":"4545_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00277-011-1307-z","volume":"91","author":"SH Lim","year":"2012","unstructured":"Lim SH, Pathapati S, Langevin J, Hoot A. Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine. Ann Hematol. 2012;91(4):643\u20134.","journal-title":"Ann Hematol"},{"issue":"3","key":"4545_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00277-014-2182-1","volume":"94","author":"T Hasegawa","year":"2015","unstructured":"Hasegawa T, Aisa Y, Shimazaki K, Nakazato T. Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol. 2015;94(3):515\u20137.","journal-title":"Ann Hematol"},{"key":"4545_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00277-017-3005-y","volume":"96","author":"S Yamasaki","year":"2017","unstructured":"Yamasaki S, Kohno K, Kadowaki M, Takase K, Iwasaki H. Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine. Ann Hematol. 2017;96:1215\u20137.","journal-title":"Ann Hematol"},{"issue":"4","key":"4545_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","volume":"137","author":"N Naderi","year":"2013","unstructured":"Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. Arch Pathol Lab Med. 2013;137(4):580\u20135.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"4545_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1309\/AJCP15YFULCZHZVH","volume":"135","author":"FH Barakat","year":"2011","unstructured":"Barakat FH, Medeiros LJ, Wei EX, Konoplev S, Lin P, Jorgensen JL. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy. Am J Clin Pathol. 2011;135(3):365\u201373.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"4545_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood.V95.2.627","volume":"95","author":"D Jones","year":"2000","unstructured":"Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000;95(2):627\u201332.","journal-title":"Blood"},{"issue":"10","key":"4545_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1172\/JCI5409","volume":"103","author":"J Dechanet","year":"1999","unstructured":"Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest. 1999;103(10):1437\u201349.","journal-title":"J Clin Invest"},{"issue":"12","key":"4545_CR11","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1002\/1521-4141(200212)32:12<3756::AID-IMMU3756>3.0.CO;2-E","volume":"32","author":"K Ellefsen","year":"2002","unstructured":"Ellefsen K, Harari A, Champagne P, Bart PA, S\u00e9kaly RP, Pantaleo G. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur J Immunol. 2002;32(12):3756\u201364.","journal-title":"Eur J Immunol"},{"key":"4545_CR12","first-page":"5762525","volume":"2017","author":"L Modvig","year":"2017","unstructured":"Modvig L, Boyle C, Randall K, Borg A. Severe cytomegalovirus reactivation in patient with low-grade non-Hodgkin\u2019s lymphoma after standard chemotherapy. Case Rep Hematol. 2017;2017:5762525.","journal-title":"Case Rep Hematol"},{"issue":"1","key":"4545_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","volume":"7","author":"J Styczynski","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018;7(1):1\u201316.","journal-title":"Infect Dis Ther"},{"issue":"6","key":"4545_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3109\/10428194.2012.739285","volume":"54","author":"T Hosoda","year":"2013","unstructured":"Hosoda T, Yokoyama A, Yoneda M, Yamamoto R, Ohashi K, Kagoo T, Ueno H, Boku S, Yano T. Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma. 2013;54(6):1327\u20138.","journal-title":"Leuk Lymphoma"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4545-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:12:51Z","timestamp":1603235571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4545"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4545-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent approved by the local ethics committee was obtained from the subject prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report competing financial interests in relation to the work described. Giulia Marchetti is a member of the Editorial Board of BMC Infectious Diseases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"881"}}